Students

Main navigation

The 2018 BIC Retreat

Monday, December 10, 2018 08:45to18:00

聽Usine C, 1345 Avenue Lalonde, Montr茅al, QC, H2L 5A9, CA/bicCategory:聽BIC Lectures

Read more about The 2018 BIC Retreat

MEG@麻豆色情片 Comprehensive Training (Second Edition)

Monday, November 16, 2015toFriday, November 20, 2015

It is with great pleasure that we are announcing the 2nd edition of the MEG@麻豆色情片 Comprehensive Training Program in 2015.3801 rue University, Montreal, QC, H3A 2B4, CA/bicCategory:聽MNI

Read more about MEG@麻豆色情片 Comprehensive Training (Second Edition)

Neuro Epilepsy Lecture Series: AI in Epilepsy: From Diagnosis to Continuous Monitoring

Thursday, September 25, 2025 16:00to17:00

The 2024-2025 Neuro Epilepsy Lecture Series will include eight lectures covering hot topics in basic and clinical epilepsy research./neuroCategory:聽Medicine and Health Sciences MNI

Read more about Neuro Epilepsy Lecture Series: AI in Epilepsy: From Diagnosis to Continuous Monitoring

iPSC Seminars: Early Drug Discovery Unit (EDDU)

Thursday, October 2, 2025 11:00to12:00

THE NEURO'S EDDU iPSC SEMINAR SERIES聽 Modeling 伪-Synuclein Pathology Spreading in a 3D Human Midbrain-Striatal Assembloid/neuroCategory:聽Medicine Research Medicine and Health Sciences MNI

Read more about iPSC Seminars: Early Drug Discovery Unit (EDDU)

Genetic sequencing project receives more than $8 million in funding

Published: 18 March 2025

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians...

Read more about Genetic sequencing project receives more than $8 million in funding

Six principal investigators from The Neuro receive CIHR grants

Published: 10 February 2025

Projects include important research on Parkinson鈥檚, glioblastoma and dementia 聽

Read more about Six principal investigators from The Neuro receive CIHR grants

Latest Alzheimer鈥檚 drug shown less effective in females than males

Published: 18 March 2025

Since becoming only the second Alzheimer鈥檚-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...